SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-May-24 8:05 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 20-May-24 | Disposition | 344,163 | -- | -- | (100%) 344.16K to 0 | |
10-May-24 7:26 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 08-May-24 | Option Exercise | 271,792 | $2.46 | $669,403.00 | 376% 72.37K to 344.16K | |
05-Jan-24 6:08 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 04-Jan-24 | Grant | 48,000 | -- | -- | 197% 24.37K to 72.37K | |
04-Jan-21 8:41 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 31-Dec-20 | Payment of Exercise | 3,923 | $12.60 | $49,429.80 | (14%) 28.29K to 24.37K | < 1% |
01-Jul-20 7:24 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 30-Jun-20 | Payment of Exercise | 3,923 | $9.71 | $38,092.30 | (12%) 32.22K to 28.29K | (64%) |
27-Jan-20 6:01 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 23-Jan-20 | Grant | 32,217 | -- | -- | 100% 0 to 32.22K |